Overcoming Clinical Trial Design Challenges in a Phase I/II Phase Myelodysplastic syndrome study
Publié le
IDDI selected by a Sponsor as the full biometric partner including eClinical tools (EDC & RTSM), data collection, data cleaning…
Publié le
IDDI selected by a Sponsor as the full biometric partner including eClinical tools (EDC & RTSM), data collection, data cleaning…
Publié le
A Bayesian Study Design For Seamless Transition Between Phase II And Phase III Data collected by a sponsor suggested a…
Publié le
A Flexible Study Design with Randomization to Placebo The maximum tolerated dose of a new drug, supposed to alleviate some…
Publié le
A new ophthalmic drug was going to enter a phase II dose-ranging trial in order to determine the dose to…
Publié le
A multi-center phase II trial was conducted in just over 100 patients to compare metabolic changes in the prostate after…